Cancer Management & Treatment | Cancer Research & Drug Trials

Top News

Many Patients With Locally Advanced Rectal Cancer Can Forgo Pelvic Radiation

Adjuvant Osimertinib Improves OS in EGFR-Mutant, Early-Stage NSCLC

Vorasidenib May Be New Standard Care for IDH1/2-Mutated Glioma

Zanidatamab Yields Durable Responses in HER2+ Biliary Tract Cancer

Adding Dostarlimab to Chemotherapy Improves PFS in Endometrial Cancer

Neoadjuvant Nivolumab Plus Relatlimab Appears Safe and Effective in NSCLC

Some Patients With HER2+ Early Breast Cancer Can Safely Forgo Chemotherapy

Tucatinib Plus Trastuzumab Shows Activity in HER2+ Metastatic Biliary Tract Cancer

UCPVax Prompts Immune Responses in MGMT Unmethylated Glioblastoma

No Benefit Seen With Adjuvant Nivolumab in Gastric/GEJ Cancer

Ribociclib Plus ET Dubbed “New Treatment of Choice” in HR+, HER2- Breast Cancer

Obecabtagene Autoleucel Appears Safe, Effective in Relapsed/Refractory B-ALL

EDITORIAL ADVISORY BOARD

Barbara Ann Burtness, MD

Steven Cohen, MD

E. David Crawford, MD

Don S. Dizon, MD, FACP

Jeffrey M. Farma, MD

Neal D. Shore, MD, FACS

Mark A. Socinski, MD

Mario Sznol, MD

Click here for complete profiles

Featured

ASCO 2023

News from the ASCO Annual Meeting 2023
Update on Bladder Cancer Risk Factors

A recent review provided an update on traditional and novel risk factors for bladder cancer that may help guide prevention efforts.
State of Cancer Research: Impact of COVID-19, Brexit, War, and Other Global Events

In the last few years, cancer research has been hindered by the COVID-19 pandemic, Brexit, the war in Ukraine, and tensions between world superpowers.
Global Survey Suggests RCC Patients Are Underinformed, Face Obstacles to Care

Results of a global survey highlight areas for improvement in the care of patients with renal cell carcinoma.
Lack of Access to Abortion Has Had a Negative Impact on Cancer Care

Since the US Supreme Court overturned Roe v Wade last year, restrictions on access to abortion have had a negative impact on cancer care.

More Features

Lung cancer

AACR 2023 Highlights Novel Research in NSCLC and ES-SCLC

By

Tori Rodriguez, MA, LPC, AHC

Ibrutinib No Longer Approved for MCL, MZL: How This Change Will Affect Patients

By

Mary Ellen Schneider

Could Shopping Data Be Used to Predict Cancer and Diagnose It Earlier?

By

Carina Storrs, PhD

Could mRNA Vaccines Help Prevent Recurrence in Pancreatic Cancer?

By

Alan P. Lyss, MD

ART and Pediatric Cancer: Risk May Vary by Method Used, Cancer Type

By

Carina Storrs, PhD

More Features »

Fact Sheets

Vaccination

Fact Sheet: COVID-19 Vaccine Considerations for Patients With Cancer

COVID-19 testing

What to Expect: Enrolling on a Cancer Clinical Trial During COVID-19